• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Analyst Buy Ratings Put Arteris Stock And Quarterly Results In Focus

    Simply Wall St·10/23/2026 08:25:29
    语音播报
    • Arteris has already reported that it would release third quarter 2026 results and host a same day conference call and webcast, putting near term execution on revenue, costs and design activity firmly under the microscope.
    • Fresh attention on Arteris system IP for complex and chiplet based chips highlights how customer adoption and design wins could shape its longer term revenue mix.
    • This discussion will examine how the Arteris investment narrative is influenced by rising chiplet demand and the upcoming quarterly earnings release.
    Spot potential peers to Arteris riding the same chiplet and system IP trend by scanning our hand picked list of 55 AI infrastructure stocks.

    Arteris Investment Narrative Recap

    To own Arteris, you need to believe chiplet and AI driven complexity will keep pushing customers toward outsourced system IP and that the current loss making model can eventually support healthier margins as scale builds. The upcoming third quarter 2026 report is unlikely to change that core thesis on its own, but it will spotlight how efficiently Arteris is converting design activity into revenue.

    The most immediate catalyst is clear execution on licensing, royalty ramps and cost discipline, especially with R&D and field engineering spending already heavy. The key risk remains that operating losses persist if big deals slip, major customers insource network on chip technology or chiplet adoption moves more slowly than expected.

    The scheduled third quarter 2026 earnings release on November 5 and the same day conference call matter because they give you a fresh look at how Arteris is managing this chiplet focused opportunity set. You get updated numbers around revenue of US$84.6 million, ongoing net losses of US$39.5 million and how remaining performance obligations are trending.

    That disclosure also intersects with the recent fair value estimate reset to about US$37.29 and the ongoing discussion around customer concentration and continued operating losses. The call should help you judge whether the business is adding design wins in AI, automotive and enterprise computing fast enough to support the chiplet and system IP story while keeping cash burn, dilution and customer dependency in check.

    Arteris' narrative points to revenues of US$162.9 million and earnings of US$19.6 million by 2029, based on analyst assumptions of 24.4% yearly revenue growth and an earnings swing of roughly US$59.1 million from earnings today of a US$39.5 million loss.

    Discover why Arteris' fair value indicates a 95% potential upside to its current price, a gap that could narrow quickly.

    NasdaqGM:AIP 1-Year Stock Price Chart
    NasdaqGM:AIP 1-Year Stock Price Chart

    Exploring Other Perspectives

    One bullish twist on Arteris focuses on the chiplet royalty mix rather than the current losses. The most optimistic analysts were projecting revenue of about US$194.1 million and earnings of roughly US$31.0 million by 2029 before this earnings date was set. You can treat those forecasts as one end of a wide opinion spectrum that may shift after the November 5 release.

    Explore 3 other Arteris fair value estimates, including one that suggests as much as 172% upside from the current price!

    Form Your Own Verdict

    Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

    Looking For More Investment Ideas Beyond Arteris?

    If the Arteris setup has you thinking about broader opportunities in your portfolio, it can help to line it up against a wider field of potential candidates using the Simply Wall St Screener.